Functional role of transporter Slc4a11 (BTR1/NaBC1) in the cornea

转运蛋白 Slc4a11 (BTR1/NaBC1) 在角膜中的功能作用

基本信息

  • 批准号:
    8243356
  • 负责人:
  • 金额:
    $ 23.66万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-12-01 至 2013-11-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Congenital hereditary endothelial dystrophy (CHED) causes impaired vision resulting from opacification of the cornea. The recessive form of CHED (CHED2) as well as some types of Fuch's endothelial dystrophy and Harboyan syndrome were recently shown to be associated with mutations in the SLC4A11 gene that encodes BTR1/NaBC1, a member of the bicarbonate transporter family. The function and subcellular location of this protein in cornea are unknown, and there is currently no adequate animal model for the study of CHED caused by SLC4A11 mutations. The goals of the proposed experiments are to determine the molecular function of SLC4A11 and its localization in the cornea, and to generate a mouse model for CHED2. The available functional information suggests that SLC4A11 transports Na+ and borate [B(OH)4- ], although no boron transport experiments with this protein have been performed. Specific Aim 1A is to use HEK293 cells and a corneal endothelial cell line, with mass-spectrometry, to determine whether mammalian (mouse, human) SLC4A11 cotransports Na+ and boron. Specific Aim 1B is to use Xenopus oocytes, with ion-selective microelectrodes, to determine whether SLC4A11 cotransports Na+ and HCO3-. In Specific Aim 2 we will perform immunohistochemistry to determine whether Slc4a11 is located in the basolateral or apical membrane of the mouse corneal endothelium. In Specific Aim 3 we will generate and evaluate the phenotype of a mouse model of CHED2 prepared by introducing, to mouse Slc4a11, a point mutation (in the position of human R755Q) that is known to cause CHED2 in humans. PUBLIC HEALTH RELEVANCE: Maintenance of transparency of the cornea is essential for good vision. A variety of conditions can cause the cornea to become cloudy, including an inherited condition known as congenital hereditary endothelial dystrophy (CHED). Some forms of CHED are a result of mutations in a transport protein known as SLC4A11, the function of which has not been well established. The goals of this project are to determine the function of SLC4A11 and to establish a mouse model of CHED.
描述(申请人提供):先天性遗传性内皮细胞营养不良症(CHED)因角膜混浊导致视力受损。隐性的CHED(CHED2)以及某些类型的Fuch型内皮营养不良和哈博扬综合征最近被证明与编码BTR1/NaBC1的SLC4A11基因突变有关,BTR1/NaBC1是重碳酸盐转运体家族的成员。该蛋白在角膜中的功能和亚细胞定位尚不清楚,目前还没有合适的动物模型来研究SLC4A11突变引起的CHED。该实验的目的是确定SLC4A11的分子功能及其在角膜中的定位,并建立CHED2的小鼠模型。现有的功能信息表明,SLC4A11可以转运Na+和B(OH)4-,尽管还没有对该蛋白进行过硼转运实验。具体目的是利用HEK293细胞和角膜内皮细胞系,用质谱仪测定哺乳动物(小鼠、人)SLC4A11是否共转运Na+和B。具体目的1B是利用非洲爪哇卵母细胞,在离子选择性微电极上,确定SLC4A11是否共转运Na+和HCO3-。在特定目的2中,我们将进行免疫组织化学以确定SLC4a11是否位于小鼠角膜内皮的基底膜或顶膜。在具体目标3中,我们将产生并评估CHED2小鼠模型的表型,该模型是通过将已知导致人类CHED2的点突变(位于人R755Q的位置)引入小鼠SLC4a11而制备的。 与公众健康相关:保持角膜的透明度对良好视力至关重要。多种情况会导致角膜混浊,包括一种称为先天性遗传性内皮细胞营养不良(CHED)的遗传性疾病。某些形式的CHED是一种名为SLC4A11的运输蛋白突变的结果,其功能尚未很好地确定。本项目的目的是确定SLC4A11的功能,并建立CHED小鼠模型。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL L JENNINGS其他文献

MICHAEL L JENNINGS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL L JENNINGS', 18)}}的其他基金

Functional role of transporter Slc4a11 (BTR1/NaBC1) in the cornea
转运蛋白 Slc4a11 (BTR1/NaBC1) 在角膜中的功能作用
  • 批准号:
    8389867
  • 财政年份:
    2011
  • 资助金额:
    $ 23.66万
  • 项目类别:
ERYTHROCYTE POTASSIUM TRANSPORT AND VOLUME REGULATION
红细胞钾转运和容量调节
  • 批准号:
    2218479
  • 财政年份:
    1995
  • 资助金额:
    $ 23.66万
  • 项目类别:
BIOCHEMICAL STUDIES OF ERYTHROCYTE TRANSPORT PROTEINS
红细胞转运蛋白的生物化学研究
  • 批准号:
    2174824
  • 财政年份:
    1987
  • 资助金额:
    $ 23.66万
  • 项目类别:
BIOCHEMICAL STUDIES OF ERYTHROCYTE TRANSPORT PROTEINS
红细胞转运蛋白的生物化学研究
  • 批准号:
    2174823
  • 财政年份:
    1987
  • 资助金额:
    $ 23.66万
  • 项目类别:
BIOCHEMICAL STUDIES OF ERYTHROCYTE ANION EXCHANGE
红细胞阴离子交换的生物化学研究
  • 批准号:
    2882991
  • 财政年份:
    1987
  • 资助金额:
    $ 23.66万
  • 项目类别:
BIOCHEMICAL STUDIES OF ERYTHROCYTE ANION TRANSPORT
红细胞阴离子转运的生物化学研究
  • 批准号:
    3274301
  • 财政年份:
    1987
  • 资助金额:
    $ 23.66万
  • 项目类别:
BIOCHEMICAL STUDIES OF ERYTHROCYTE TRANSPORT PROTEINS
红细胞转运蛋白的生物化学研究
  • 批准号:
    2174825
  • 财政年份:
    1987
  • 资助金额:
    $ 23.66万
  • 项目类别:
ERYTHROCYTE POTASSIUM TRANSPORT AND VOLUME REGULATION
红细胞钾转运和容量调节
  • 批准号:
    2218478
  • 财政年份:
    1987
  • 资助金额:
    $ 23.66万
  • 项目类别:
BIOCHEMICAL STUDIES OF ERYTHROCYTE ANION EXCHANGE
红细胞阴离子交换的生物化学研究
  • 批准号:
    2634629
  • 财政年份:
    1987
  • 资助金额:
    $ 23.66万
  • 项目类别:
MECHANISMS OF SULFATE TRANSPORT AND REGULATION
硫酸盐运输和调节机制
  • 批准号:
    7193533
  • 财政年份:
    1987
  • 资助金额:
    $ 23.66万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 23.66万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 23.66万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 23.66万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.66万
  • 项目类别:
    Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 23.66万
  • 项目类别:
    Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 23.66万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 23.66万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
  • 批准号:
    10639161
  • 财政年份:
    2023
  • 资助金额:
    $ 23.66万
  • 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
  • 批准号:
    10752441
  • 财政年份:
    2023
  • 资助金额:
    $ 23.66万
  • 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
  • 批准号:
    10867639
  • 财政年份:
    2023
  • 资助金额:
    $ 23.66万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了